Clinical Hospital Dubrava

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Crohn's disease1 trial
• Heart failure1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Alfasigma S.p.A.1 trial
• European Society of Cardiology1 trial
• Kartos Therapeutics, Inc.1 trial
• Takeda1 trial

Running trials

• Enrolling by invitation

  Snapshot Study on Patients With Heart Failure

  NCT06469814· European Society of Cardiology· Source

• Recruiting

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· Phase 3· Kartos Therapeutics, Inc.· Source

  Contact: John Mei

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· Phase 3· Alfasigma S.p.A.· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source